Cargando…
Dexamethasone/favipiravir/antibacterials: Cytomegalovirus pneumonia, Candida parapsilosis infection and off label use: case report
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Springer International Publishing
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417684/ http://dx.doi.org/10.1007/s40278-021-01664-1 |
Ejemplares similares
-
Dexamethasone: Off label treatment and Candida parapsilosis infection
Publicado: (2021) -
Prednisolone/dexamethasone: Candida endophthalmitis and cytomegalovirus infection of vitreous fluid following off-label use: case report
Publicado: (2022) -
Dexamethasone/favipiravir/methylprednisolone: Hyperglycaemia, masking of cytokine storm and off-label use: 2 case reports
Publicado: (2021) -
Dexamethasone/favipiravir/metoclopramide: Sinus bradycardia, deranged liver enzymes and off-label use: case report
Publicado: (2021) -
Adalimumab/anakinra/dexamethasone: COVID-19 infection, cytomegalovirus reactivation and off-label use: case report
Publicado: (2020)